• Home
  • Agric
  • Sci & Tech
  • Health
  • Environment
  • Hausa News
  • More
    • Business/Banking & Finance
    • POLITICS
    • Entertainments & Sports
    • International
    • Investigation
    • Law & Human Rights
    • Africa
    • ACCOUNTABILITY/CORRUPTION
    • Hassan Gimba
    • Column
    • Prof. Jibrin Ibrahim
    • Prof. M.K. Othman
    • Defense/Security
    • Education
    • Energy/Electricity
    • Entertainment/Arts & Sports
    • Society and Lifestyle
    • Food & Agriculture
    • Health & Healthy Living
    • International News
    • Interviews
    • Investigation/Fact-Check
    • LAW & HUMAN RIGHTS
    • Oil & Gas/Mineral Resources
    • PRESS FREEDOM/JOURNALISM/PR
    • General News
    • Presidency
  • About Us
    • Contact Us
    • Board Of Advisory
    • Privacy Policy
    • Ethics Policy
    • Teamwork And Collaboration Policy
    • Fact-Checking Policy
    • Advertising
  • Media OutReach Newswire
    • Wire News
  • The Stories
Facebook Twitter Instagram
Trending
  • Land loss, ageing farmers put smallholders at risk
  • Africa pushes for climate finance, adaptation action ahead of COP32
  • Media credibility crucial to success of 2027 polls – GOCOP president
  • NEMA distributes relief materials to Abia windstorm, erosion victims
  • Radda flags off ₦1.4bn Ingawa hospital upgrade
  • LAWMA targets faster waste removal in 60-day plan
  • NAFDAC seizes, destroys ₦100bn worth of unsafe products
  • Jigawa confirms 242 diphtheria cases across 19 LGAs
Facebook Twitter Instagram YouTube
AsheNewsAsheNews
  • Home
  • Agric

    Land loss, ageing farmers put smallholders at risk

    November 22, 2026

    Nigeria’s coffee growers face an uphill road to recognition

    November 21, 2026

    Ogun farmers call for better roads, security, inputs

    November 20, 2026

    Kaduna poultry farmers struggle with feed costs

    November 20, 2026

    Enugu residents call for steps to stabilise onion prices

    November 20, 2026
  • Sci & Tech

    Foreign AI Chatbots could expose patients’ medical data

    November 21, 2026

    GTA VI claims biggest launch in entertainment history

    November 21, 2026

    Expert calls for wider access to digital services in Nigeria

    November 20, 2026

    Rural connectivity key to inclusive digital growth, expert says

    November 20, 2026

    IAR, NBMA train stakeholders on managing low-level presence of GM crops

    November 20, 2026
  • Health

    Radda flags off ₦1.4bn Ingawa hospital upgrade

    November 21, 2026

    LAWMA targets faster waste removal in 60-day plan

    November 21, 2026

    NAFDAC seizes, destroys ₦100bn worth of unsafe products

    November 21, 2026

    Jigawa confirms 242 diphtheria cases across 19 LGAs

    November 21, 2026

    Rotary takes free cancer screening to Plateau community

    November 21, 2026
  • Environment

    Africa pushes for climate finance, adaptation action ahead of COP32

    November 21, 2026

    NEMA distributes relief materials to Abia windstorm, erosion victims

    November 21, 2026

    Bayelsa boat accident renews concerns over waterway safety

    November 21, 2026

    Ghana warns of El Niño-linked health risks as harmattan intensifies

    November 20, 2026

    Ghana’s UCC Vice-Chancellor meets 12-year-old student, urges focus on excellence

    November 20, 2026
  • Hausa News

    Foundation unveils public sector reform playbook

    November 12, 2026

    Tinubu asks Reps to approve N10.79tn external borrowing for 2026 budget

    November 11, 2026

    UNA signs MoU to launch air Bissau in Guinea-Bissau

    June 15, 2026

    Otti plans 250-room 5-star hotel in Umuahia

    April 11, 2026

    Anti-quackery task force seals 4 fake hospitals in Rivers

    August 29, 2025
  • More
    1. Business/Banking & Finance
    2. POLITICS
    3. Entertainments & Sports
    4. International
    5. Investigation
    6. Law & Human Rights
    7. Africa
    8. ACCOUNTABILITY/CORRUPTION
    9. Hassan Gimba
    10. Column
    11. Prof. Jibrin Ibrahim
    12. Prof. M.K. Othman
    13. Defense/Security
    14. Education
    15. Energy/Electricity
    16. Entertainment/Arts & Sports
    17. Society and Lifestyle
    18. Food & Agriculture
    19. Health & Healthy Living
    20. International News
    21. Interviews
    22. Investigation/Fact-Check
    23. LAW & HUMAN RIGHTS
    24. Oil & Gas/Mineral Resources
    25. PRESS FREEDOM/JOURNALISM/PR
    26. General News
    27. Presidency
    Featured
    Recent

    Land loss, ageing farmers put smallholders at risk

    November 22, 2026

    Africa pushes for climate finance, adaptation action ahead of COP32

    November 21, 2026

    Media credibility crucial to success of 2027 polls – GOCOP president

    November 21, 2026
  • About Us
    1. Contact Us
    2. Board Of Advisory
    3. Privacy Policy
    4. Ethics Policy
    5. Teamwork And Collaboration Policy
    6. Fact-Checking Policy
    7. Advertising
    Featured
    Recent

    Land loss, ageing farmers put smallholders at risk

    November 22, 2026

    Africa pushes for climate finance, adaptation action ahead of COP32

    November 21, 2026

    Media credibility crucial to success of 2027 polls – GOCOP president

    November 21, 2026
  • Media OutReach Newswire
    • Wire News
  • The Stories
AsheNewsAsheNews
Home»Health & Healthy Living»UNAIDS, experts slam $28,000 HIV drug price despite global need
Health & Healthy Living

UNAIDS, experts slam $28,000 HIV drug price despite global need

EditorBy EditorJune 22, 2025Updated:June 22, 2025No Comments4 Mins Read
AIDS
Share
Facebook Twitter LinkedIn Pinterest Email

Reactions continue to follow the recent approval of Yeztugo, a twice-yearly injectable medication for HIV prevention, with global health experts warning that its high cost could exclude millions of vulnerable people from accessing it.

Speaking in Abuja on Sunday, experts expressed both optimism and caution about the development.

The United States Food and Drug Administration (FDA) recently approved long-acting injectable Lenacapavir for HIV prevention. Administered once every six months, the drug represents a major leap forward in expanding global prevention options for people at high risk of infection.

In two major clinical trials completed in 2024, Gilead’s injection, marketed as Yeztugo, was shown to be highly effective, virtually eliminating new HIV infections when taken twice a year.

Its low-dose frequency makes it a more convenient alternative to existing options like daily oral PrEP pills (Truvada and Descovy) and GSK’s Apretude, which requires a bimonthly injection.

Gilead CEO Daniel O’Day described the approval as a turning point, saying, “This really will bend the arc of the epidemic as we roll this out globally.”

However, global concern erupted following Gilead’s announcement of a $28,218 annual price tag per patient in the United States.

Health advocates and HIV organizations warn that such a price point will put the life-saving drug out of reach for many, particularly in low- and middle-income countries.

A study published in The Lancet HIV this week estimates that generic Lenacapavir could be produced for as little as $35 to $46 per person annually, and potentially as low as $25 with consistent demand. This would make it cost-comparable with existing oral PrEP options.

Winnie Byanyima, Executive Director of UNAIDS and United Nations Under-Secretary-General, welcomed the FDA’s decision but demanded immediate action on access and affordability.

“Lenacapavir could be the tool we need to bring new infections under control, but only if it is priced affordably and made available to everyone who could benefit,” she said.

“This is a breakthrough moment. The approval of Lenacapavir is a testament to decades of public investment, scientific excellence, and the contributions of trial participants and communities. It is beyond comprehension how Gilead can justify a price of $28,218. If this game-changing medicine remains unaffordable, it will change nothing.”

Professor Oyewale Tomori, a virologist and former President of the Nigerian Academy of Science, also praised the scientific advancement but emphasized that the situation underscores Africa’s structural disadvantages in accessing medical innovations.

“Until African countries begin to produce and manufacture their vaccines and treatments, such disparities in access are to be expected,” he said. “We must invest significantly in local research, biotechnology, and pharmaceutical development. Only through self-reliance can the continent avoid being left behind during global health breakthroughs.”

Jeremiah Johnson, Executive Director of PrEP4All, stressed the need to move beyond scientific achievement toward real-world impact.

“It’s not enough to have the science; we need it in the hands of those who need it most,” he said.

Gilead, in response to criticism, announced that it would offer copay assistance to reduce out-of-pocket costs to zero for eligible insured individuals in the United States, and provide free access to qualifying uninsured patients. The company also expects broad insurance coverage for Yeztugo, as with other HIV prevention treatments.

Lenacapavir is already approved for HIV treatment under the brand name Sunlenca, with a list price exceeding $42,000 per year in the U.S.

To support global access, Gilead has licensed six generic manufacturers to produce low-cost versions of Lenacapavir in 120 low- and lower-middle-income countries. The company also pledged to supply up to two million doses at no profit before generic alternatives become widely available.

The company reiterated that HIV knows no boundaries and emphasized its commitment to equitable access.

Despite daily PrEP pills being available for more than a decade, their use has been limited in many communities due to stigma, inconvenience, and adherence challenges—especially outside the demographic of white men who have sex with men.

As Gilead prepares for global rollout of Yeztugo, public health advocates stress the importance of ensuring this innovation becomes a symbol of inclusion and access, rather than a new source of inequality.

HIV HIV Prevention UNAIDS Yeztugo
Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Editor
  • Website

Related Posts

Radda flags off ₦1.4bn Ingawa hospital upgrade

November 21, 2026

LAWMA targets faster waste removal in 60-day plan

November 21, 2026

NAFDAC seizes, destroys ₦100bn worth of unsafe products

November 21, 2026

Leave A Reply Cancel Reply

Land loss, ageing farmers put smallholders at risk

November 22, 2026

Africa pushes for climate finance, adaptation action ahead of COP32

November 21, 2026

Media credibility crucial to success of 2027 polls – GOCOP president

November 21, 2026

NEMA distributes relief materials to Abia windstorm, erosion victims

November 21, 2026
About Us
About Us

ASHENEWS (AsheNewsDaily.com), published by PenPlus Online Media Publishers, is an independent online newspaper. We report development news, especially on Agriculture, Science, Health and Environment as they affect the under-reported rural and urban poor.

We also conduct investigations, especially in the areas of ASHE, as well as other general interests, including corruption, human rights, illicit financial flows, and politics.

Contact Info:
  • 1st floor, Dogon Daji House, No. 5, Maiduguri Road, Sokoto
  • +234(0)7031140009
  • ashenewsdaily@gmail.com
Facebook Twitter Instagram Pinterest
© 2026 All Rights Reserved. ASHENEWS Daily Designed & Managed By DeedsTech

Type above and press Enter to search. Press Esc to cancel.